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Abstract
Introduction: Traditionally, assessment in axial Spondyloarthritis (aSpA) includes the evaluation of the capacity to execute
tasks, conceptualized as physical function. The role of physical activity, defined as movement-related energy expenditure, is
largely unknown and almost exclusively studied using patient-reported outcome measures. The aims of this observational
cross-sectional study are to compare physical activity between patients with aSpA and healthy controls (HC) and to evaluate
the contribution of disease activity to physical activity differences between groups.
Methods: Forty patients with aSpA were matched by age, gender, period of data acquisition in terms of days and season to
40 HC. Physical activity was measured during five consecutive days (three weekdays and two weekend days) using
ambulatory monitoring (SenseWear Armband). Self-reported disease activity was measured by the Bath Ankylosing
Spondylitis Disease Activity Index (BASDAI). Differences in physical activity between patients with aSpA and HC were
examined with Wilcoxon signed-rank tests and a mixed linear model. Difference scores between patients and HC were
correlated with disease activity.
Results: Average weekly physical activity level (Med(IQR); HC:1.54(1.41–1.73); aSpA:1.45(1.31–1.67),MET) and energy
expenditure (HC:36.40(33.43–41.01); aSpA:34.55(31.08–39.41),MET.hrs/day) were significantly lower in patients with aSpA.
Analyses across intensity levels revealed no significant differences between groups for inactivity and time spent at light or
moderate physical activities. In contrast, weekly averages of vigorous (HC:4.02(1.20–12.60); aSpA:0.00(0.00–1.20),min/d), very
vigorous physical activities (HC0.00(0.00–1.08); aSpA:0.00(0.00–0.00),mind/d) and moderate/(very)vigorous combined
(HC2.41(1.62–3.48); aSpA:1.63(1.20–2.82),hrs/d) were significantly lower in patients with aSpA. Disease activity did not
interact with differences in physical activity between patients with aSpA and HC, evidenced by non-significant and very low
correlations (range: 20.06–0.17) between BASDAI and HC-aSpA patients’ difference scores.
Conclusions: Patients with aSpA exhibit lower physical activity compared to HC and these differences are independent of
self-reported disease activity. Further research on PA in patients with aSpA should be prioritized.
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Introduction
The concept of spondyloarthritis embodies a family of
rheumatic diseases characterized by distinct processes of tissue
inflammation, destruction and/or pathological bone formation.
Articular features typically occur at the synovio-entheseal complex
[1,2], but also extra-articular features such as uveitis and psoriasis
may complicate disease [3]. Clinically, a predominantly axial or
peripheral articular presentation or a combination of both
subtypes can be distinguished [4,5]. In axial spondyloarthritis
(aSpA), inflammatory back pain, stiffness and mobility impairment
contribute to limitations in activities and restrictions in societal
participation [4,6].
Physical activity (PA) can be defined as any bodily movement
produced by contraction of skeletal muscle that substantially
increases energy expenditure [7]. Community-based PA interven-
tions for people with arthritis in general have shown to improve
physical function, decrease pain, delay functional decline and
reduce costs [8,9]. Despite this ample interest in PA in patients
with arthritis in general, PA is a neglected construct in the aSpA
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e85309
literature [10]. The Assessment of SpondyloArthritis international
Society (ASAS) expert group and the European League Against
Rheumatism recommended exercise, a structured and planned
form of PA [7], as a decisive part of the non-pharmacological
treatment of ankylosing spondylitis (AS), [11]. Exercise programs
for patients with AS, the hallmark aSpA condition, traditionally
include flexibility exercises with only minor benefits on physical
function, spinal mobility and patient global assessment at best
[12,13]. Typically, these programs fail to deliver the optimal PA
intensity according to the American College of Sports Medicine
(ACSM) recommendations to develop health-related physical
fitness in terms of cardio-respiratory endurance, muscular strength
and body composition [12]. In contrast to other arthritis
subgroups such as rheumatoid arthritis and osteoarthritis, the
efficacy and safety of PA in relation to health outcomes is unknown
for aSpA. Limited evidence from cross-sectional studies indicates a
role for PA to improve fatigue [14], body composition [15] and
quality of life [16], similar to findings in the healthy population.
However, if patients exhibit less PA [15–17] and different i.e.
disease-specific PA patterns compared to healthy controls is largely
unknown. These data are needed to guide health policy and set
research priorities.
PA assessment is currently not included in the ASAS minimal
core set to monitor patients with aSpA in both clinical practice and
research [18]. The key domain ‘physical function’ reflects
difficulties in executing physical activities, not their amount or
intensity, and is evaluated with the self-reported Bath Ankylosing
Spondylitis Functional Index [19,20]. Since both expert rheuma-
tologists and rehabilitation experts in the aSpA field increasingly
recognize the need to establish the possible dose-dependent effects
of PA [12,16,21], novel PA assessment strategies such as
accelerometry are needed. Further, low correlations between PA
and physical function measures in rheumatoid arthritis [22] or
osteoarthritis [23] indicate that these related but distinct concepts
should be assessed separately to optimally describe functioning.
Taken together, establishing the role of PA in aSpA may lead to
new perspectives on both the assessment of functioning and
efficacy of PA on several clinical outcomes. This study investigated
the role of self-reported disease activity in explaining PA
differences.
To our best knowledge, this is the first study that aimed to
identify differences in weekly PA between patients with aSpA and
healthy controls using objective monitoring of PA in free-living
conditions with a sophisticated multi-sensor device. Additionally,
between and within group differences in PA will be explored for
each timepoint (weekdays, Saturday and Sunday) to further detect
different PA patterns. Lastly, this study aimed to unravel the role
of disease activity in explaining the observed differences in PA
between patients with aSpA and healthy controls.
Materials and Methods
Subjects
Forty patients with aSpA were consecutively recruited from our
spondyloarthritis outpatient clinic at the University Hospitals
Leuven. Axial SpA diagnosis was verified by an expert rheuma-
tologist according to the European Spondylarthropathy Study
Group criteria [5]. Exclusion criteria were: 1) history of spinal
fractures or other fractures within 12 months, lower quadrant
musculoskeletal injuries not related to SpA, discitis, pregnancy,
spondylolisthesis, spondylolysis, 2) current symptoms of severe
health conditions (eg. heart failure) that would influence the PA
assessment according to the principal investigator, 3) not being
able to stand or walk without an aid. An experienced physical
therapist ascertained exclusion criteria using the patient’s medical
record and the Self-administered Co-morbidity Questionnaire
[24]. Forty healthy controls, matched by gender, age and period of
data acquisition (season and monitoring days), were randomly
selected from a large study on PA in Flemish adults [25]. A
random number calculator (www.randomization.com) guided the
selection procedure within strata of possible matches. All subjects
provided written informed consent prior to participation. The
study protocol was written in accordance to the Declaration of
Helsinki and was approved by the Medical Ethics Committee of
the University Hospitals Leuven (ML 5236).
Measurements
Disease activity. The Bath Ankylosing Spondylitis Disease
Activity Index (BASDAI), originally developed in patients with AS,
is the widely accepted and ASAS endorsed disease-specific
instrument to assess disease activity in aSpA [26]. The BASDAI
questionnaire comprises six questions to evaluate the severity of
fatigue, peripheral and axial pain, localized tenderness and
morning stiffness during the last week. The psychometric
properties of the BASDAI are well established [27–29].
Physical activity. The SenseWear Pro 3 Armband (Body-
Media, Pittsburgh, USA) is a multi-sensor device containing a two-
axial accelerometer and sensors measuring heat flux, galvanic skin
response, skin temperature and near-body ambient temperature.
The armband is positioned over the triceps muscle of the right
arm. Algorithms provided by the manufacturer combine the
sensor data with age, body weight, height, gender, smoking status
and handedness to produce minute-by-minute estimates of energy
expenditure (kcal), physical activity intensity (metabolic equivalent)
and number of steps. Axial SpA patients and healthy controls were
instructed to continuously wear the Armband for 5 and 7
consecutive days respectively, except during water-based activities
which were reported in a non-wear log. A valid day was defined as
a wear time of minimally 1296 minutes, which corresponds to
90% of a 24 hour period. To avoid bias, we selected the same
weekdays in patients and healthy controls. Anthropometric
measures were taken by the same observer at the moment of the
outpatient visit, prior to the monitoring period. Height was
measured with a stadiometer (Holtain Ltd, Dyfed, UK) to the
nearest 0,1 cm and weight was measured with a digital scale
(SECA, Birmingham, UK) to the nearest 0,1 kg. PA parameters
were calculated for weekdays (average of three weekdays),
Saturday and Sunday. Furthermore, a weekly average was
estimated by the formula: ((parameteraverage weekday * 5)+para-
meterSaturday+parameterSunday)/7. Physical activity level (PAL) and
energy expenditure (EE) both reflected the average daily energy
expenditure, expressed as a multiple of the resting metabolic rate
of 1 metabolic equivalent (1 MET=1 kcal/kg/hr) and in
MET.hrs/d, respectively. Time spent at different PA intensity
levels was obtained using MET-values. MET-values #1.8 were
considered to reflect inactivity, whereas MET-values .1.8 and,3
were defined as light activity [30]. MET-values $3 and ,6 were
classified as moderate activities. Vigorous activities were char-
acterised by MET-values $6, but ,9. MET-values $9 indicated
very vigorous activities [31]. MET-values $3 reflected the overall
health enhancing moderate and (very)vigorous physical activity
(MVPA) estimate. The validity of the SenseWear in assessing these
PA parameters is established in both healthy [32] and diseased
persons [33].
Data analysis
Continuous descriptive data of patients and healthy controls
were contrasted using a paired t-test to account for the matched
Physical Activity in Axial Spondyloarthritis
PLOS ONE | www.plosone.org 2 February 2014 | Volume 9 | Issue 2 | e85309
nature of the study and Chi-squared tests for proportions
(p,0.05). The primary outcome analyses involved: 1) the comparison
of weekly average PA parameters between aSpA patients and
controls using a Wilcoxon signed-rank test and 2) the verification
of an interaction effect of disease activity on all PA comparisons
between patients with aSpA and healthy controls. Difference
scores within each matched pair (controls minus patients) were
calculated and correlated with disease activity (BASDAI) with
Spearman rank correlation coefficients. Because of the typical and
large difference in work status between groups that may explain
observed PA inequalities, we also correlated work status with PA
difference scores using the point biserial correlation coefficient
(spearman rank coefficient yielded the same results). A significant
(p,0.05) and moderate (.0.30) coefficient was a priori set as the
threshold for an interaction effect [34]. The secondary outcome
analyses were exploratory comparisons (no a priori power
calculations for this part) of PA parameters 1) between groups at
any of the individual timepoints namely weekdays, Saturday and
Sunday, 2) within each group across all timepoints and 3) between
groups to detect different change patterns in PA estimates across
all timepoints. All comparisons required longitudinal analyses
whereby both the timepoints and groups were regarded as
repeated measures. A general linear model which models
covariances was employed using the MIXED procedure in SAS
version 9.3 (SAS Institute, Cary, USA). For both timepoints and
group, an unstructured covariance matrix was assumed. The
model included fixed effects for time, group and their interaction.
Model assumptions of constant variance and normality of the
residuals were assessed by visual inspection of residual plots. Log-
transformation was applied to PAL and EE to correct distorted
residuals. However, log-transformation still yielded inappropriate
residuals for time spent at light, moderate, vigorous, very vigorous
and MVPA. For these parameters, the first and third types of
comparison were made by means of a Friedman’s test. To assess
whether there was a difference between the groups at any time, a
generalized estimating equations (GEE) model with identify link
and normal distribution for the residuals was employed using
sandwich estimators for the estimation of the (co)variances since it
has been shown that this analysis yields consistent results, even if
the model assumptions have not been satisfied. Post-hoc tests
pairwise comparisons were made using Wilcoxon signed-rank
tests. In order to attain a probability of 95%, p-values were
Bonferroni corrected by multiplying them by 3.
Results
Demographics and disease related characteristics are presented
in Table 1 and indicate successful matching. During non-wear
time, neither patients nor healthy controls reported additional PA.
Full data are given in Table S1 available on the PLOS ONE
website.
Weekly physical activity between groups
Results of our primary outcome analysis are given in Table 2.
Weekly PAL (p= 0.048) and EE (p= 0.045) were significantly
lower in patients with aSpA (Table 2, Figure 1A). No differences
between groups were found for weekly time spent at inactivity,
light or moderate PA. For the latter, a trend for less moderate PA
in patients was observed (p = 0.07). A lack of vigorous (p,0.001)
and very vigorous (p,0.001) weekly PA in patients with aSpA
versus controls was detected (Figure 1C, 1D, 3), in addition to
reduced levels of MVPA combined (p= 0.029; Table 2, Figure 1B).
Role of disease activity and work status
Disease activity did not interact with differences in weekly PA
between patients and controls, evidenced by non-significant and
very low correlations between BASDAI and difference scores
ranging from 20.06 to 0.17 (Table 3, Figure 2). Similarly low and
non-significant correlations between work status and difference
scores were observed ranging from 20.11 to 0.12 (detailed data
available from the corresponding author upon request).
Differences between groups at time points
Concerning the secondary outcome analyses, significant differ-
ences between groups at any time point were found only for
vigorous (p,0.001), very vigorous PA (p = 0.015) and MVPA
(p= 0.028) (see Table S1). Patients were spending less time at
vigorous PA on weekdays (p,0.001) and Saturday (Figure 3A,
p,0.001). Significantly less very vigorous PA on weekdays
(Figure 3B, p= 0.015) and less MVPA on Saturday (p= 0.021)
was found in patients. All plots have shown a pattern of less PA in
aSpA patients at each time point (Figures not shown, additional
figures available upon request from the corresponding author).
Differences within groups at timepoints
Several significant effects within the aSpA group were detected
(Table S1, EE: p= 0.039, light PA: p= 0.049; vigorous PA:
p= 0.009). The visually clear lower EE on Sunday compared to
Saturday (p = 0.097) and increased MVPA on Saturday (p= 0.397)
did not reach significance. In contrast, patients with aSpA were
showing significantly more time spent at light PA on weekdays
compared to Sunday (p= 0.021). Also, patients were spending
significantly more time at vigorous PA (Figure 3A) on weekdays
compared to Saturday (p = 0.027), but not on Saturday compared
to Sunday (p= 0.128). Significant effects within the healthy control
group were identified for time spent inactive (p = 0.013) and at
light PA (p = 0.020), with less inactive time on Saturday compared
to Sunday (p = 0.012) and with more light PA on weekdays than
Sunday (p= 0.004).
Change profile across timepoints between groups
No significant differences in overall within group change
patterns between patients with aSpA and controls were found
(p.0.05, Table S1). Visual inspection of all graphs (Figures not
shown, but available on request from the corresponding author)
has revealed quite stable PA estimates in aSpA patients across
timepoints, while more variability on Saturday in the healthy
control group was reflected both in the plots and quartile ranges
(Table S1).
Discussion
This is the first study demonstrating differences in PA between
patients with aSpA and healthy controls using technology-based
PA assessment. The lower weekly average estimates of PAL and
EE observed indicate that total PA is reduced in patients with
aSpA. To date, only three studies compared total PA between
patients with aSpA and healthy controls. Marcora [17] studied
disease-related cachexia in 19 patients with AS and 19 age-matched
controls. To exclude PA behaviour as a non disease-related
confounder of body composition, they compared self-reported PA
levels between groups. With a p-value of 0.052 their analysis almost
reached significance for lower PA levels in patients. From a Swedish
registry study including self-reported PA, Haglund [16] concluded
that patients with spondyloarthritis are slightly more likely to meet
PA recommendations than healthy controls and both groups exhibit
sufficient PA (about 70%) in general. Cultural differences and
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over-reporting of PA in survey research may explain these
inconsistencies with other studies on PA around the globe [25,31].
Using a less sophisticated 3-axial accelerometer, Plasqui [15] found
no differences in weekly PAL in a group of 25 patients with AS
matched to healthy controls by gender, age and body mass. They
observed a PAL (mean) between 1.70 and 1.99 indicating the
selection of active or moderately active patients and controls, while
our study sample can be classified as sedentary or light active with
PAL values between 1.40 and 1.69 according to the World Health
Organization guidelines on energy requirements [35]. In contrast to
this work, the study of Plasqui [15] presented with a high risk of bias
due to the small sample size (n= 25), the recruitment of first degree
relatives as controls (about half the sample), no control for seasonal
effects on PA and an inappropriate non-wear description (waking
hours instead of 90% data of 24 hours period in this study). As we
confirmed lower total PA with an objective methodology, we feel
that research and maybe health policy on PA in aSpA should be
prioritized.
This is the first study in the aSpA field that compared patients
and controls across different PA intensity levels. We established a
lack of weekly time spent at (very)vigorous PA and reduced
MVPA, while only a trend for less moderate intensity PA between
patients with aSpA and healthy controls was observed. The
American College of Sports Medicine/American Heart associa-
tion (ACSM/AHA) PA guideline recommends moderate intensity
PA for a minimum of 30 min on five days each week or vigorous
intensity PA for a minimum of 20 min on three days each week to
maintain health [31]. Population surveys indicate that persons
with self-reported doctor-diagnosed arthritis are less likely to meet
PA guidelines for both moderate and vigorous activities (30 and
21%) compared to persons without arthritis (33 and 24%) [36].
We found that patients with aSpA and healthy controls spent on
average 98 and 137 minutes (2.29 and 1.63 hrs) per day at
moderate intensity and 0 and 4 minutes per day (0 and 0.07 hrs) at
(very) vigorous PA. Both patients with aSpA and healthy controls
appear to outperform the ACSM/AHA guideline for moderate,
but not vigorous activities. Also, apparently sufficient levels but
Table 1. Demographics of healthy controls and patients with axial spondyloarthritis (aSpA).
Healthy controls n=40 aSpA patients n =40 p-value
Gender Men (n (%)) 24 (60%) 24 (60%) NA
Women (n (%)) 16 (40%) 16 (40%) NA
Work status (n with job (%)) 39 (98%) 25 (63%) ,.001
$
Weight (kg) 75.69613.31 76.36617.12 .847"
Height (cm) 173.6369.75 170.15610.13 .121"
Body Mass Index (kg/m2) 25.0563.59 26.2765.11 .219"
Age (years) 44.33610.63 44.38611.30 .984"
SWA wear-time (hrs/d) 23.7160.17 23.6760.03 .501"
Disease duration (years) NA 11.4069.50 NA
BASDAI (0–10) NA 3.6962.59 NA
Peripheral joints (0–10)* NA 3.1062.97 NA
BASFI NA 3.5262.50 NA
Cervical rotation (u)# NA 62.41614.61 NA
Tragus to wall distance (cm)# NA 13.2363.73 NA
Chest expansion (cm) NA 4.0661.98 NA
Lumbar side flexion# NA 11.2364.09 NA
Modified Scho¨ber Index (cm)# NA 3.5961.00 NA
Intermalleolar distance (cm)# NA 97.43620.00 NA
BASMI (0–10) NA 3.0561.21 NA
TSK-AA (11–44) NA 13.8363.28 NA
NSAIDs (n (%)) NA 21 (52,5%) NA
Biologicals (n (%)) NA 19 (47,5%) NA
Analgesics (n (%)) NA 14 (35%) NA
DMARDs (n (%)) NA 8 (20%) NA
Corticosteroids (n (%)) NA 0 (0%) NA
Psychopharmaca (n (%)) NA 3 (7,5%) NA
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; BASMI, Bath Ankylosing Spondylitis Metrology Index;
NSAIDs, Non-Steroidal Anti-Inflammatory Drugs; DMARDs, Disease-Modifying AntiRheumatic Drugs; SWA, SenseWear Armband; TSK-AA, Tampa Scale for Kinesiophobia
Activity Avoidance subscale;
*item 3 BASDAI;
#based on BASMI;
"paired t-test (p,.05);
$
chi-square test (p,.05);
NA, not applicable.
doi:10.1371/journal.pone.0085309.t001
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Figure 1. Individual physical activity data between controls (n =40) and patients with axial spondyloarthritis (n =40): physical
activity level expressed in metabolic equivalent (MET) (A), time spent at moderate and (very)vigorous physical activity (MVPA) in
hrs/d (B), time spent at vigorous (C) and very vigorous (D) physical activities in min/d; *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0085309.g001
Table 2. Comparison of physical activity parameters between healthy controls and patients with axial spondyloarthritis (aSpA).
Healthy controls (n =40)# aSpA patients (n =40)# p-value"
Weekly averages*
PAL (MET) 1.54 (1.41–1.73) 1.45 (1.31–1.67) .048
EE (MET.hrs/d) 36.40 (33.43–41.01) 34.55 (31.08–39.41) .045
Inactive (hrs/d) 17.85 (16.44–18.95) 17.99 (16.83–19.17) .450
Light PA (hrs/d) 3.28 (2.73–4.10) 3.87 (2.73–4.48) .288
Moderate PA (hrs/d) 2.29 (1.53–3.22) 1.63 (1.20–2.80) .070
(min/d)** 137.40 (91.80–193.20) 97.80 (72.00–168.00) .070
Vigorous PA (hrs/d) 0.07 (0.02–0.21) 0.00 (0.00–0.02) ,.001
(min/d)** 4.02 (1.20–12.60) 0.00 (0.00–1.20) ,.001
Very vigorous PA (hrs/d) 0.00 (0.00–0.03) 0.00 (0.00–0.00) ,.001
(min/d)** 0.00 (0.00–1.08) 0.00 (0.00–0.00) ,.001
MVPA (hrs/d) 2.41 (1.62–3.48) 1.63 (1.20–2.82) .029
(min/d)** 144.71 (96.98–208.05) 98.19 (71.93–169.26) .029
#Data are presented as median (quartile range); PAL, physical activity level; EE, energy expenditure; PA, physical activity; MVPA, moderate/(very)vigorous physical
activity combined;
*for a total week estimate, multiply values with seven;
**estimates transformed to minutes to facilitate interpretation;
"Wilcoxon signed-rank tests, significant results in bold, p,0.05.
doi:10.1371/journal.pone.0085309.t002
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clinically relevant group differences in health enhancing MVPA
were found (47 min less aSpA group). As this guideline only takes
PA bouts of 10 minutes or more into account and allows
combinations of moderate and vigorous activities to minimally
accumulate 450 MET.min/week, direct comparison with our
study data is impossible [31]. By including a control group, our
study truthfully shows a disease-related loss of vigorous, very
vigorous and moderate/(very)vigorous combined PA participation
in patients with aSpA. Similarly, Farr [37] applied accelerometry
in a sample of patients with osteoarthritis and observed a dramatic
drop in patients who met the ACSM guideline for time spent at
vigorous activities (men 2%, women 1%). In addition, the scarcity
of time spent at vigorous and very vigorous intensity levels
probably explains the differences in weekly average PAL and EE
in patients versus controls. Last, although minimally clinically
important difference estimates in aSpA do not exist for the PA
estimates under study, the differences between groups exceeded
measurement error [38] and are similar to treatment effects in
other populations [39].
To date, PA studies in aSpA have mainly focused on the role of
PA on other outcomes. Da Costa [14] concluded that higher doses
of leisure time PA determined by a structured interview were
associated with less fatigue severity in aSpA patients with a normal
mental status, while this effect was absent for patients reporting a
poor mental status as measured with the SF-36 health survey’s
mental component subscore. Ward [40] has identified high PA
intensities at work as a predictor of structural damage and activity
limitations in AS. The latter finding points to the question whether
the observed reduction of time spent in vigorous and very vigorous
activity levels is adaptive (i.e. protective to the underlying disorder)
or maladaptive (i.e. compromising the underlying disorder or
other health outcomes) in the context of aSpA [2,41]. On one
hand, a role for entheseal biomechanical stress in the develop-
ment/maintenance of inflammation and/or damage in aSpA was
recently proposed [2,42]. The observed stable and lower levels of
Figure 2. Scatterplots of healthy control versus axial spondyloarthritis (aSpA) difference scores and disease activity as measured
by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI): Physical activity level (PAL) A) and Vigorous PA (B); PA,
physical activity; MET, metabolic equivalent; diff, difference score: for each matched pair (n=40 pairs) healthy control value minus
aSpA patient value.
doi:10.1371/journal.pone.0085309.g002
Table 3. Spearman correlation coefficients between disease activity (BASDAI*) and difference scores between healthy controls
(HC) and patients with axial spondyloarthritis (aSpA) for all weekly average physical activity parameters (n = 40).
HC-aSpA patients difference scores# R" p-value
Weekly averages**
PAL (MET) 0.14 (0.40) 0.07 .656
EE (MET.hrs/d) 3.15 (9.64) 0.08 .605
Inactivity (hrs/d) 20.25 (2.87) 20.02 .881
Light PA (hrs/d) 20.49 (2.32) 20.06 .710
Moderate PA (hrs/d) 0.43 (3.33) 0.17 .300
Vigorous PA (hrs/d) 0.07 (0.19) 20.04 .815
Very vigorous PA (hrs/d) 0.00 (0.03) 0.06 .706
MVPA (hrs/d) 0.66 (2.09) 0.12 .452
#Data are presented as median (quartile range);
*BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; PA, physical activity; PAL, physical activity level; EE, energy expenditure; MVPA, moderate/(very)vigorous
physical activity combined;
**for a total week estimate, multiply values with seven;
"Correlation coefficients were neither significant nor relevant, no interaction was observed, p,0.05.
doi:10.1371/journal.pone.0085309.t003
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PA in the aSpA group may be an effective strategy to alleviate
aSpA disease processes. Indeed, the most frequently reported
arthritis-specific coping strategy by patients is changing PA in
terms of duration, frequency and intensity to complete an ongoing
task [43]. On the other hand, a relationship between PA and
cardiovascular health exists [31] and refraining from (very)
vigorous activities may add to the increased cardiovascular risk
of patients with aSpA [3]. Thus, increasing PA without vast
entheseal biomechanical stress may be of uttermost importance to
optimize health-related physical fitness in these patients. A large
body of evidence from intervention studies supports only moderate
effects of exercise to improve pain, stiffness, mobility impairment,
patient’s global assessment and activity limitations [13]. Ince et al.
[38] targeted energy expenditure in line with the ACSM/AHA
guidelines to develop cardio-respiratory endurance patients with
AS. Although core outcomes such as pain were not evaluated, the
large effect sizes found for improvement in aerobic capacity point
to rehabilitation opportunities in aSpA. Our finding that disease
activity did not affect the observed differences between patients
and healthy controls also suggests possibilities for PA intervention.
Caution is however needed, because small but significant negative
associations between total physical activity and both C-reactive
protein [15] and BASDAI [16] were reported. In addition, no
golden standard is available to assess disease activity and we only
focused on self-reported disease activity. Future randomised
studies including a wide spectrum of imaging, clinical (patient
and physician perspective) and laboratory measures of disease
activity may fully appreciate the role of disease activity. Also, as
nor disease activity or work status, by intuition strong candidates
to explain low PA, explained the PA differences observed, future
Figure 3. Vigorous (A) and very vigorous (B) physical activities (PA) expressed in min/d for patients with axial spondyloarthritis
(aSpA, n=40) and matched healthy controls (n =40). Horizontal lines represent median values for weekly average and time point
estimates; *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0085309.g003
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research should focus on the identification of modifiable determi-
nants of PA behaviour to promote health. For now, we interpret
our finding as a non-recovery of reduced PA due to high disease
activity, that needs a tailored rehabilitation approach beyond
disease control.
The ASAS expert group recently embraced the World Health
Organization’s International Classification of Functioning, Dis-
ability and Health (WHO/ICF) framework to standardize the
assessment of functioning in aSpA [44]. Unfortunately, the ASAS/
WHO/ICF core sets [44–47] fail to recognize the crucial
distinction between what a person can do in a standardized
environment (activities) versus in a real-life situation (participation)
[48]. More problematic is the continued use of self-reported
outcome measures to appreciate functioning, possibly biased by
psychological factors such as depression and anxiety [49]. This
study adds to the optimal assessment of functioning in aSpA by
quantifying the ‘amount of’ instead of ‘difficulty with’ movement-
related participations and by introducing an unbiased objective
measurement instrument in the patient’s own environment.
The fact that our weekdays PA estimates were based on three
instead of five weekdays may be considered as a limitation of this
study. Because subjects were instructed to wear the SenseWear
armband day and night, minimizing monitoring days based on a
stability threshold established in healthy controls was needed to
minimize patient burden without compromising validity [25,50].
To our opinion, high levels of compliance, matching days and
season, and the participant’s similar cultural background has
resulted in accurate measures of habitual PA in both groups. Also,
in our exploratory part, pairwise comparisons between groups at
each time point and the observed higher variability of PA in
healthy controls across timepoints that may relate to different
change profiles between groups did not turn out significant,
possibly indicating a lack of power. Only the primary outcomes
comparing weekly PA between groups and evaluating the role of
disease activity can be confidently interpreted.
Conclusions
This is the first study establishing differences in PA between
patients with aSpA and healthy controls using objective multi-
sensor PA measures. Major findings were reduced weekly average
energy expenditure and time spent at vigorous, very vigorous and
moderate/(very)vigorous combined PA in patients with aSpA.
Interestingly, disease activity did not affect the observed disparities
in PA. Therefore, unraveling the relationship between PA and
clinical outcomes in patients with aSpA should be a research and
maybe health policy priority.
Supporting Information
Table S1 Detailed comparison of physical activity
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